The tumor-intrinsic mechanism mainly refers to low tumor mutation burden (TMB) and expression of PD-L1, loss of neoantigen expression, deficiency of antigen presentation, activation of driver genes, and dysfunction of specific pathways in tumor cells. The gene discussed is CD274; the disease is neoplasm.